Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...
Transcranial magnetic stimulation, or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials ...
The GLP-1 medications have been linked to decreased risks of heart disease, kidney disease and Alzheimer’s disease, as well as increased fertility and a reduction in alcohol cravings.